Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
N/A
30,716 Added 239.18%
43,558 $42,000
Q2 2023

Jul 27, 2023

SELL
N/A
-17,458 Reduced 57.62%
12,842 $9,000
Q1 2023

May 01, 2023

BUY
N/A
30,300 New
30,300 $20,000

Others Institutions Holding BBI

About Brickell Biotech, Inc.


  • Ticker BBI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,873,960
  • Market Cap $6.75M
  • Description
  • Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary ...
More about BBI
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.